Charles E Umstott, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 500 J Clyde Morris Blvd, Suite 602, Newport News, VA 23601 Phone: 757-534-5511 Fax: 757-534-5515 |
William L Old Iii, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 500 J Clyde Morris Blvd, Ste 602, Newport News, VA 23601 Phone: 757-534-5511 Fax: 757-534-5515 |
Paul Lawson Evans Jr., MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 500 J Clyde Morris Blvd, Suite 602, Newport News, VA 23601 Phone: 757-534-5511 Fax: 757-534-5515 |
Dr. Djurabek Babadjanov, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 500 J Clyde Morris Blvd Ste 603, Newport News, VA 23601 Phone: 757-534-5340 Fax: 757-534-3456 |
News Archive
Blindness and eye problems may seem far in the future for children and teenagers with diabetes. But a new study shows these concerns shouldn't be overlooked in those with the condition — of any age.
Six Case Western Reserve scientists are part of an international team that has discovered two compounds that show promise in decreasing inflammation associated with diseases such as ulcerative colitis, arthritis and multiple sclerosis.
XenoPort, Inc. announced today that new data from its first clinical trial of XP21279, a Transported Prodrug of L-Dopa, in Parkinson's disease patients will be presented at the upcoming World Parkinson Congress meeting in Glasgow, Scotland.
Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been identified as endogenous peptide antagonist andinverse agonistof CXCR4 and is a promising compound for the development of improved analogues for the therapy of CXCR4-associated diseases.
A new technique that searches blood for the tiniest remnants of broken down proteins has revealed new information about how cells crank up cancer activators called proteases. The results improve researchers' understanding of the mechanics of breast cancer and point to where to look for possible indicators of early disease.
› Verified 5 days ago